NextPlat Completes Pensacola-Area Acquisition of Profitable Pharmacy, Accelerating Continued Healthcare Growth and Profitability

The acquired pharmacy generated approximately $5.6 million in 2025 sales and operated profitably with a debt-free balance sheet.

Rhea-AI Summary

NextPlat (NXPL) completed the acquisition of an independent pharmacy near Pensacola, Florida, for total cash consideration of $1,485,439.

The purchase includes the pharmacy and its inventory. For the year ended December 31, 2025, the pharmacy generated approximately $5.6 million in sales. It was profitable, maintained positive working capital and operated with a debt-free balance sheet. NextPlat expects the pharmacy to contribute to growth and profitability in its PharmcoRx healthcare segment throughout the fourth quarter.

Integration into the PharmcoRx network is underway. NextPlat plans to introduce higher-margin contracted services for 340B, long-term care and senior living providers to enhance the pharmacy's profitability. The company is also exploring acquisitions of other established, profitable community operators. PharmcoRx currently operates five pharmacies across Florida.

8 points · 0 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

• Moderate pointCompleted pharmacy acquisition expands NextPlat's presence into a rural community near Pensacola, Florida.
• Moderate pointAcquired pharmacy generated approximately $5.6 million in sales for the year ended December 31, 2025.
• Minor pointAcquired pharmacy was profitable, supporting NextPlat's expansion through an operating business.
• Minor pointAcquired pharmacy maintained positive working capital.
• Minor pointAcquired pharmacy operated with a debt-free balance sheet.

3 minor points

• Minor point. Forward-looking: it has not happened yet and may not happen.NextPlat expects the pharmacy to contribute to PharmcoRx growth and profitability throughout the fourth quarter.
• Minor point. Forward-looking: it has not happened yet and may not happen.NextPlat plans to introduce higher-margin contracted services for 340B, long-term care and senior living providers.
• Minor point. Forward-looking: it has not happened yet and may not happen.NextPlat is exploring additional acquisitions of established, profitable community pharmacy operators.

Negative

• Moderate pointPharmacy and inventory acquisition required $1,485,439 in total cash consideration. 6.1% of market cap

Key Figures

Cash consideration: $1,485,439 2025 sales: Approximately $5.6 million

Cash consideration

$1,485,439

Pharmacy and inventory acquisition

2025 sales

Approximately $5.6 million

Pharmacy sales for the year ended December 31, 2025

Previous Acquisition Reports

1 past event · Latest: Jul 15

Same Type 1 event

1. Jul 15

   Pharmacy acquisition

   24h Move

   -5.4%

   The prior agreement specified $1.5 million in cash and targeted closing in Q4 2026.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

340b

1 terms

340b technical

"contracted services for 340B, long-term care and senior living providers"

340B is a U.S. federal program that lets qualifying hospitals and clinics buy outpatient prescription drugs at steep, government-negotiated discounts so they can stretch limited budgets and serve low-income or uninsured patients. For investors, 340B affects how much drugmakers earn on certain sales and how safety-net providers generate margin—think of it like a factory discount card that changes both the seller’s revenue and the buyer’s ability to reinvest savings in operations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Strategic Acquisition Enhances Pharmacy Diversification into Underserved Market, Supporting the Launch of New High-Value, High Margin Healthcare Services for Regional Providers and Patients

HALLANDALE BEACH, Fla., Oct. 6, 2026 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced that it has completed the previously announced strategic acquisition of an independent pharmacy ("the Pharmacy") in a rural community near Pensacola in the panhandle region of northwest Florida.

NextPlat acquired the Pharmacy and its inventory for total cash consideration of $1,485,439. For the year ended December 31, 2025, the Pharmacy generated approximately $5.6 million in sales. The Pharmacy was profitable, maintained positive working capital, and operated with a debt-free balance sheet and is expected to contribute to the continued growth and profitability in the Company's PharmcoRx healthcare segment throughout the fourth quarter.

"This acquisition synergistically expands our pharmacy footprint in Florida, adding access to the large Pensacola market and to the greater panhandle region where we have an opportunity to rapidly introduce our full array of high-value service offerings to local patients and providers," said David Phipps, CEO of NextPlat. "Our teams are quickly working to integrate this pharmacy into our growing PharmcoRx network and see a clear path to enhancing its profitability as we layer in our higher-margin contracted services for 340B, long-term care and senior living providers across a region where those offerings are largely unavailable today. Looking ahead, as we continue to grow organically, we are actively exploring additional opportunities to acquire well-established, profitable community operators that can provide us with diversification and further differentiate our business from traditional mass market retail pharmacies."

NextPlat's PharmcoRx unit currently operates five pharmacies serving patients in northern, central, and southern Florida providing full-service prescription fulfillment, medication management, high-touch, same day delivery, and integrated patient support and coordination with healthcare providers. Beyond traditional retail pharmacy services, PharmcoRx also provides higher margin contracted services including medication fulfillment, claims management and compliance reporting to 340B providers as well as to long-term care, senior living communities and government agencies.

Additional information on this transaction may be found in the Current Reports on Form 8-K that will be filed by NextPlat with the U.S. Securities and Exchange Commission (the "SEC").

For more information about NextPlat, please visit www.NextPlat.com and connect with us on Facebook, LinkedIn and X.

About NextPlat Corp
NextPlat is a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the Company seeks to provide access to high-quality healthcare and pharmacy services supporting patients, providers, institutions, and public-sector organizations and creating online sales channels for the sales of products to domestic and international consumers. Through its subsidiaries, NextPlat provides pharmacy and healthcare data management services and prescription fulfillment services in the United States and operates an e-commerce division offering voice, data, tracking, and IoT products and services worldwide.

Forward-Looking Statements
Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to successfully acquire and integrate pharmacies, and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (financial or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.

Media and Investor Contact for NextPlat Corp:
Michael Glickman
MWGCO, Inc.
917-397-2272
mike@mwgco.net

View original content to download multimedia:https://www.prnewswire.com/news-releases/nextplat-completes-pensacola-area-acquisition-of-profitable-pharmacy-accelerating-continued-healthcare-growth-and-profitability-302899226.html

SOURCE NextPlat Corp.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did NextPlat pay for the pharmacy near Pensacola?

NextPlat paid $1,485,439 in total cash consideration for the pharmacy and its inventory. The acquisition has been completed.

Was the pharmacy acquired by NextPlat profitable?

The acquired pharmacy was profitable and generated approximately $5.6 million in sales for the year ended December 31, 2025. It maintained positive working capital and operated with a debt-free balance sheet.